Skip to content

Association of Haptoglobin 2-2 With Postoperative Delirium

Determination of the Association of Haptoglobin 2-2 With Delirium After Orthopedic Surgery

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03392480
Enrollment
0
Registered
2018-01-08
Start date
2017-12-20
Completion date
2019-12-30
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

Patients with major orthopedic surgery will be recruited. Participants will be monitored for delirium after surgery. Participants' blood will be harvested for the determination of haptoglobin types, levels of oxidative stress and inflammation. Investigators will then analyze the data to see if haptoglobin 2-2 type is associated with an increased postoperative delirium, inflammation and oxidative stress.

Interventions

None listed

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum

Inclusion criteria

* American Society of Anesthesiologists physical status I to III class for major orthopedic surgery (hip or knee replacement or spinal surgery) * No psychological and psychiatric history and presentation before surgery * No major organ dysfunction or failure

Exclusion criteria

* Anemia (hemoglobin \< 100 g/l) preoperatively. * Requires \> 4 units of allogeneic red blood cell transfusion during the surgery * Using steroids or anti-psychological and anti-psychiatric drugs. A small dose of steroid for postoperative anti-nausea/vomiting is allowed and will not be considered as a indication for exclusion. * Can not cooperate with the study * History of bleeding * BMI \< 18 or \> 30 * History of hemoglobin metabolism disorder

Design outcomes

Primary

MeasureTime frameDescription
Postoperative delirium incidenceFrom day 0 to up to 7 days after the surgeryThe incidence of delirium as assessed by intensive care unit-confusion assessment method will be determined.
Postoperative delirium durationFrom day 0 to up to 7 days after the surgeryThe duration of delirium as assessed by intensive care unit-confusion assessment method will be determined.

Secondary

MeasureTime frameDescription
Oxidative stress levelDay 0 to day 2 after the surgeryThe level of malondialdehyde in the blood will be measured by ELISA.
Inflammation levelDay 0 to day 2 after the surgeryThe levels of interleukin 1beta and interleukin 6 in the blood will be assessed by ELISA.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026